Fact check: the Oxford-AstraZeneca vaccine’s effectiveness in older people
New data suggests jab may reduce Covid transmissions by 67%
Suggestions that the Oxford-AstraZeneca vaccine may not be effective on older patients have been dealt a further blow after new data suggests that it eliminates the most serious form of Covid and may have a “substantial impact” on Covid transmission as well as symptoms.
Research by the University of Oxford, published in a pre-print report with The Lancet, found that the jab showed a 67% reduction in positive Covid-19 tests in those who had been vaccinated. And a “single dose eliminates severe illness among those who contract the virus”, The Times reports.
The study throws more doubt on the German health ministry’s decision to advise against giving the vaccine to over-65s, a plan that goes against the recommendations of the European Medicines Agency (EMA).
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
What has Germany said?
A statement by the Standing Vaccine Commission at the Robert Koch Institute, Germany’s main public health agency, said there were “insufficient data currently available to ascertain how effective the vaccination is above 65 years”.
The German decision results from the relatively small number of over-65s involved in the trial. AstraZeneca chief executive Pascal Soirot told La Repubblica this week that the initial trial group was younger because “it was not ethical to vaccinate old people until they had enough safety data”.
Soirot added: “The data is showing a good level of antibodies in elderly, as you see in younger people”.
What does that mean for the UK?
The trials of the vaccine “did recruit fewer elderly people overall”, writes the BBC’s health editor Michelle Roberts. However, “the scientists who ran the trials have always been upfront about this” and “say there is other evidence to suggest the vaccine will work well in older adults”.
“Studies show the over 65s have strong immune responses to the vaccine”, she adds. “After receiving the shots their blood has plenty of the required antibodies that can fight coronavirus.”
The new research published in The Lancet found that a single dose of the Oxford-AstraZeneca vaccine is 76% effective from day 22 to day 90 after the jab. The findings “support the government’s strategy that rolling out first doses - with a second dose after three months - is effective at reducing disease”, Sky News says.
Oxford University said earlier this month that there was “no basis” for reports in the German media questioning the vaccine’s efficacy, adding that their data has already been “released transparently”. AstraZeneca also reiterated the university’s denial, describing the claims as “completely incorrect”.
AstraZeneca told German broadcaster Deutsche Welle: “In November, we published data in The Lancet demonstrating that older adults showed strong immune responses to the vaccine, with 100% of older adults generating spike-specific antibodies after the second dose.”
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Holden Frith is The Week’s digital director. He also makes regular appearances on “The Week Unwrapped”, speaking about subjects as diverse as vaccine development and bionic bomb-sniffing locusts. He joined The Week in 2013, spending five years editing the magazine’s website. Before that, he was deputy digital editor at The Sunday Times. He has also been TheTimes.co.uk’s technology editor and the launch editor of Wired magazine’s UK website. Holden has worked in journalism for nearly two decades, having started his professional career while completing an English literature degree at Cambridge University. He followed that with a master’s degree in journalism from Northwestern University in Chicago. A keen photographer, he also writes travel features whenever he gets the chance.
-
Today's political cartoons - March 16, 2024
Cartoons Saturday's cartoons - pointed commentary, Haiti in trouble, and more
By The Week US Published
-
5 hilarious cartoons about the RNC's MAGA takeover
Cartoons Artists take on RNC funding, Lara Trump, and more
By The Week US Published
-
Trump's presidential run: a bad bet for Republicans?
Talking Point The GOP is taking a 'big gamble' on former president's 2024 White House bid
By The Week UK Published
-
Excess screen time is making children only see what is in front of them
Under the radar The future is looking blurry. And very nearsighted.
By Devika Rao, The Week US Published
-
Has the international pandemic treaty lost its way?
Under The Radar 'Wrangling and disinformation' mean plans for a global preparedness agreement are close to crumbling
By Chas Newkey-Burden, The Week UK Published
-
Covid-19: what to know about UK's new Juno and Pirola variants
in depth Rapidly spreading new JN.1 strain is 'yet another reminder that the pandemic is far from over'
By Arion McNicoll, The Week UK Published
-
Long-term respiratory illness is here to stay
The Explainer Covid is not the only disease with a long version
By Devika Rao, The Week US Published
-
'100 day' whooping cough: what to know about surge in cases
Under the radar Pregnant women and children urged to get vaccinated after cases increase by 250%
By Arion McNicoll, The Week UK Published
-
Covid inquiry: the most important questions for Boris Johnson
Talking Point Former PM has faced weeks of heavy criticism from former colleagues at the public hearing
By The Week Staff Published
-
China's pneumonia cases: should we be worried?
The Explainer Experts warn against pushing 'pandemic panic button' following outbreak of respiratory illness
By Keumars Afifi-Sabet, The Week UK Published
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
By The Week UK Published